Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 6, 1997, Pages 521-527

  Carlsen, S M ^a   Folling I ^a   Grill, V ^a   Bjerve, K S ^a   Schneede, J ^b   Refsum, H ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Folate; Homocysteine; Metformin; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; METFORMIN; METHYLMALONIC ACID; MEVINOLIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030878833     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709084603     Document Type: Article

References (23)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274: 997-1092.
2. Ueland PM, Refsum H, Brattstrøm L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, editor. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992: 183-236.
3. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990; 1: 228-37.
4. Ueland PM, Refsum H, Stabler SP, Malinov MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.
5. 12.status of patients on long-term metformin therapy. Br Med J 1971; 2: 685-7.
6. Carpentier J-L, Luyckx BA, Lefebvre P. Vitamin B12 and folic acid serum levels in diabetics under various therapeutic regimens. Diabet Metab 1976; 2: 187-90.
7. 12 and folic acid absorption and intestinal enzyme activities. Scand J Gastroenterol 1971; 6: 751-4.
8. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541-9.
9. Carlsen SM, Rossvoll O, Bjerve KS, Følling I. Metformin improves the blood lipid pattern in nondiabetic patients with coronary heart disease. J Int Med 1996; 239: 227-33.
10. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263-71.
11. Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989; 35: 1921-7.
12. Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. J Am Med Assoc 1995; 274: 1526-33.
13. Schneede J, Ueland PM. Application of capillary electrophoresis with laser-induced fluorescence detection for routine analysis of methylmalonic acid in human serum. Analyt Chem 1995; 67: 812-19.
14. 12 and intrinsic factor secretion during biguanide therapy. Diabetologia 1983; 24: 16-18.
15. 12-absorption in diabetics on biguanides. Diabetologia 1977; 13: 187-93.
16. Carmel R. Subtle and atypical cobalamin deficiency states. Am J Hematol 1990; 34: 108-14.
17. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency. 1. Usefulness of serum methyl malonic acid and total homocysteine concentration. Am J Hematol 1990; 34: 90-8.
18. Pennypacker LC, Allen RH, Kelly JP. Matthews LM, Grigsby J, Kaye K, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Amer Ger Soc 1992; 40: 1197-1204.
19. Savage DG, Lindenbaum J, Stabler SP, Allan RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239-46.
20. Bergman U, Boman G, Wiholm B-E. Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J 1978; 2: 464-6.
21. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde PM, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704-9.
22. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
23. Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993; 103(2): 149-57.